This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| The Aesthetic Meeting | |
|---|---|
| Name | The Aesthetic Meeting |
| Date | Annual |
| Venue | Varies |
| Location | Varies |
| Organiser | American Society for Aesthetic Plastic Surgery |
| First | 1967 |
The Aesthetic Meeting is the annual scientific conference organized by the American Society for Aesthetic Plastic Surgery that focuses on aesthetic surgical and non-surgical procedures. It convenes clinicians, researchers, device manufacturers, and educators to present clinical studies, technical innovations, and practice management strategies. The meeting has become a focal point for exchange among practitioners affiliated with institutions such as Johns Hopkins Hospital, Massachusetts General Hospital, and Mayo Clinic, and attracts international attendees from centers like Royal Free Hospital, Rabin Medical Center, and Pitié-Salpêtrière Hospital.
The meeting features peer-reviewed sessions, hands-on workshops, and industry exhibitions showcasing devices from companies like Allergan, Galderma, AbbVie, Merz Pharmaceuticals, and Cynosure. Program elements include podium presentations, poster sessions, and cadaver labs that often highlight techniques associated with surgeons from Memorial Sloan Kettering Cancer Center, Cleveland Clinic, Stanford Health Care, UCLA Medical Center, and Mount Sinai Hospital. Attendance typically includes members of the American Society of Plastic Surgeons, International Society of Aesthetic Plastic Surgery, European Association of Plastic Surgeons, and delegations from academic centers such as Columbia University Medical Center, NewYork-Presbyterian Hospital, and University College London Hospitals.
The meeting traces origins to professional gatherings in the 1960s and was institutionalized by the American Society for Aesthetic Plastic Surgery to codify aesthetic practice standards. Early meetings drew leaders from early adopters like Dr. Thomas Rees? and colleagues from Bellevue Hospital, evolving alongside milestones at institutions such as John Hopkins University and regulatory decisions by agencies including Food and Drug Administration, and policy debates involving organizations like American Medical Association. Over decades the meeting paralleled developments exemplified by landmark innovations at Massachusetts General Hospital, technique refinements promoted at University of Pennsylvania Health System, and technology rollouts from companies such as Ethicon and Sientra.
Programs typically span multiple days with plenary sessions, breakout symposia, and skills workshops. Core curriculum components align with continuing medical education standards endorsed by bodies like American Board of Plastic Surgery and include sessions on injectable therapies presented by faculty from Harvard Medical School, laser modalities demonstrated by experts from Mayo Clinic, and reconstructive-adjacent topics from teams at Johns Hopkins School of Medicine. The exhibition hall features manufacturers such as Allergan Aesthetics, Hologic, Lumenis, and academic poster sessions representing research from University of Toronto Faculty of Medicine, University of Melbourne, and Seoul National University Hospital.
Attendees include board-certified surgeons from organizations like American Board of Plastic Surgery, trainees from programs at UCSF Medical Center and Duke University Hospital, physician assistants, nurse practitioners, practice managers, and industry representatives from firms such as Johnson & Johnson, Baxter International, and Boston Scientific. International registrants come from professional societies including the International Confederation of Plastic, Reconstructive and Aesthetic Surgeons and regional groups like the British Association of Aesthetic Plastic Surgeons and the Brazilian Society of Aesthetic Plastic Surgery.
The meeting has been the venue for influential technique descriptions, multicenter trials, and safety data analyses presented by investigators affiliated with University of California, San Francisco, Yale School of Medicine, Northwestern Memorial Hospital, University of Texas MD Anderson Cancer Center, and Karolinska Institutet. Industry-sponsored trials from Allergan and Merz have reported outcomes here, while outcomes registries and consensus statements co-sponsored by organizations such as The Aesthetic Society and ASPS have been drafted or publicized at the meeting. Presentations addressing device approvals and safety have intersected with deliberations at FDA Advisory Committee meetings and policy discussions at Centers for Medicare & Medicaid Services.
The meeting has faced scrutiny over conflicts of interest due to sponsorship by companies including Allergan, Galderma, and Sientra, raising questions similar to disputes involving American Medical Association panels and academic-industry relationships at institutions like Harvard Medical School and Stanford University School of Medicine. Debates at the meeting have mirrored controversies seen in forums such as BMJ commentary and discussions at World Health Organization consultations regarding marketing practices, patient safety, and the ethical considerations of cosmetic procedures. Specific sessions have been critiqued in outlets that cover professional controversies involving organizations such as MedPage Today and The New York Times.
Over successive decades the meeting has influenced practice patterns at hospitals and clinics including Cleveland Clinic Florida, The Johns Hopkins Hospital, and international centers such as Singapore General Hospital and Groote Schuur Hospital. Its proceedings have informed curricula at medical schools like Icahn School of Medicine at Mount Sinai and McGill University Faculty of Medicine, and contributed to procedural guidelines referenced by societies such as ASAPS and ISAPS. The meeting continues to serve as a nexus linking academic research from institutions including Imperial College London and University of Heidelberg Faculty of Medicine with commercial innovation from firms like L'Oréal and Teoxane, shaping the trajectory of aesthetic practice globally.
Category:Plastic surgery conferences